Related Experiment Video
Updated: Aug 9, 2026
12:41
Acquisition of Resting-State Functional Magnetic Resonance Imaging Data in the Rat
Published on: August 28, 2021
Sedation using dexmedetomidine in pediatric burn patients
James Walker1, Matt Maccallum, Carl Fischer
1Department of Anesthesiology, University of Cincinnati Medical Center, Cincinnati, Ohio, USA.
Summary
Dexmedetomidine (DEX) effectively sedated pediatric burn patients who failed other treatments. This alpha2-adrenergic agonist provided adequate sedation without significant respiratory depression or changes in blood glucose levels.
Area of Science:
- Pediatric intensive care
- Anesthesiology
- Burn management
Background:
- Pediatric burn patients often require high doses of analgesics and anxiolytics.
- Tolerance to opioids and benzodiazepines leads to escalating doses and increased side effects.
- Dexmedetomidine (DEX), an alpha2-adrenergic agonist, offers sedation, anxiolysis, and analgesia with less respiratory depression.
Purpose of the Study:
- To evaluate the efficacy of DEX in achieving adequate sedation in pediatric burn patients.
- To investigate the effects of DEX on blood glucose levels in this patient population.
Main Methods:
- Retrospective chart review of 65 pediatric burn patients in the ICU.
- Patients received DEX infusion due to inadequate sedation with standard opioid and benzodiazepine regimens.
- Data collected included sedation levels, blood glucose, and ventilation status before and after DEX initiation.
Main Results:
- All patients achieved adequate sedation with DEX after failing previous regimens.
- No tachyphylaxis or significant withdrawal symptoms were observed during DEX infusion or weaning.
- No significant difference in blood glucose levels was found between DEX infusion and off-DEX periods.
- No DEX-induced respiratory depression was noted, and some ventilated patients were extubated.
Conclusions:
- Dexmedetomidine is an effective alternative for sedating pediatric burn patients who are refractory to traditional sedative agents.
- DEX can be used safely without significant adverse effects on blood glucose or respiratory function in this population.
Related Concept Videos
01:24Parenteral Anesthetics: Overview
Intravenous anesthetics are drugs administered parenterally to induce anesthesia or sedation. Propofol is a widely used agent formulated as a 1% emulsion in soybean oil, glycerol, and egg phosphatide. It induces rapid anesthesia primarily due to its rapid distribution from the bloodstream to target tissues and is metabolized in the liver. However, it can cause significant pain on injection and hypertriglyceridemia. Fospropofol, a water-based prodrug of propofol, lacks these adverse effects.
01:20Inhalational Anesthetics: Overview
Inhalation anesthetics are drugs that induce general anesthesia upon inhalation. They work by increasing the sensitivity of GABAA receptors or inhibiting NMDA receptors, leading to a decrease in central nervous system activity. The depth of anesthesia can be rapidly adjusted by changing the concentration of the inhaled gas. Some common examples of inhalational anesthetics include volatile liquids like isoflurane, desflurane, sevoflurane and gases like xenon and nitrous oxide. Isoflurane, a...
01:17Sedatives and Hypnotics Drugs: Miscellaneous Agents
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
01:31Skeletal Muscle Relaxants: Therapeutic Uses
Skeletal muscle relaxants are used to relax muscle tone and alleviate painful muscle contractions. However, the choice of skeletal muscle relaxants depends on the duration of the surgical procedure in order to minimize potential side effects. Skeletal muscle relaxants like neuromuscular blocking agents [NMBAs] are commonly employed as adjuvants alongside general anesthetics in clinical settings. NMBAs are also used to maintain controlled ventilation during surgery of the larynx or pharynx as...
01:21Skeletal Muscle Relaxants: Adverse Effects
Skeletal muscle relaxants are widely used for muscle paralysis and relieving pain following any muscle injury or stiffness. However, depending on the drug type, they can have adverse effects that range from mild to severe. Usually, nondepolarizing neuromuscular blockers have minimal side effects. For example, drugs like d-tubocurarine, cisatracurium, and rocuronium cause hypotension, whereas drugs like baclofen, when stopped abruptly, can lead to the recurrence of spastic conditions.
Unlike...
Unlike...
01:23Sedatives and Hypnotics: Overview
Sedatives are drugs that alleviate anxiety, while hypnotics induce sleep. Both classes of medication suppress neuronal activity, leading to a calming effect for sedatives and facilitating sleep for hypnotics.
Sedative-hypnotics are categorized into barbiturates, benzodiazepines (BZDs), and non-benzodiazepines or Z-drugs. These drugs work by suppressing central nervous system activity, and this suppression is dose-dependent. Older sedative medications, like barbiturates, follow a linear curve in...
Sedative-hypnotics are categorized into barbiturates, benzodiazepines (BZDs), and non-benzodiazepines or Z-drugs. These drugs work by suppressing central nervous system activity, and this suppression is dose-dependent. Older sedative medications, like barbiturates, follow a linear curve in...